These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
691 related articles for article (PubMed ID: 34011758)
1. Orbital infarction syndrome secondary to rhino-orbital mucormycosis in a case of COVID-19: Clinico-radiological features. Rao R; Shetty AP; Nagesh CP Indian J Ophthalmol; 2021 Jun; 69(6):1627-1630. PubMed ID: 34011758 [TBL] [Abstract][Full Text] [Related]
2. Rhino-orbital mucormycosis in a patient with no susceptibility following P.vivax malaria infection-a case report. Prasad S; Gaur A; Mehta A; Kaushal N BMC Ophthalmol; 2022 Oct; 22(1):389. PubMed ID: 36183076 [TBL] [Abstract][Full Text] [Related]
3. Rhino-orbital mucormycosis during steroid therapy in COVID-19 patients: A case report. Veisi A; Bagheri A; Eshaghi M; Rikhtehgar MH; Rezaei Kanavi M; Farjad R Eur J Ophthalmol; 2022 Jul; 32(4):NP11-NP16. PubMed ID: 33843287 [TBL] [Abstract][Full Text] [Related]
4. Bilateral blindness in a young male of rhino-orbital-cerebral mucormycosis: A case report. Kaur R; Sehgal A; Khan B; Budhiraja G; Roychoudhury AK; Kaur M Indian J Ophthalmol; 2022 May; 70(5):1822-1824. PubMed ID: 35502084 [TBL] [Abstract][Full Text] [Related]
5. Clinico-Radiological-Pathological Correlation of Visual Loss in COVID-Associated Rhino-Orbito-Cerebral Mucormycosis. Goel R; Arora R; Shah S; Chhabra M; Kumar J; Khurana N; Gupta S; Khanam S; Kumar S; Singh S; Meher R; Thakar M; Garg A Ophthalmic Plast Reconstr Surg; 2022 May-Jun 01; 38(3):242-249. PubMed ID: 34919070 [TBL] [Abstract][Full Text] [Related]
6. Bilateral ophthalmic artery occlusion in rhino-orbito-cerebral mucormycosis. Song YM; Shin SY Korean J Ophthalmol; 2008 Mar; 22(1):66-9. PubMed ID: 18323710 [TBL] [Abstract][Full Text] [Related]
7. Exudative retinal detachment in COVID-19 - associated rhino-orbital mucormycosis - A rare clinical finding. Sarkar S; Gokhale T; Kaliaperumal S; Singh R; Begam RB; Deb AK Indian J Ophthalmol; 2021 Sep; 69(9):2535-2537. PubMed ID: 34427262 [TBL] [Abstract][Full Text] [Related]
8. Is mucormycosis the end? A comprehensive management of orbit in COVID associated rhino-orbital-cerebral mucormycosis: preserving the salvageable. Keshri A; Mathialagan A; Aishwarya A; Ravisankar ; Bhuskute G; Kanaujia V; Singh AK; Singh RK; Dhiman RK; Agarwal R Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):819-827. PubMed ID: 36053359 [TBL] [Abstract][Full Text] [Related]
9. Post-COVID-19 rhino-orbito-cerebral mucormycosis: a new addition to challenges in pandemic control. Mitra S; Janweja M; Sengupta A Eur Arch Otorhinolaryngol; 2022 May; 279(5):2417-2422. PubMed ID: 34309754 [TBL] [Abstract][Full Text] [Related]
10. COVID-19 associated rhino-orbital-cerebral mucormycosis: An observational study from Eastern India, with special emphasis on neurological spectrum. Dubey S; Mukherjee D; Sarkar P; Mukhopadhyay P; Barman D; Bandopadhyay M; Pandit A; Sengupta A; Das S; Ghosh S; Adhikari S; Biswas PS; Pal P; Roy H; Patra N; Das A; Sinha P; Mondal MK; Shrivastava SR; Bhattacharya K; Mukhopadhyay M; Ahmed K; Halder TK; Saha M; Ahmed K; Maity S; Mandal A; Chatterjee D; Saha S; Chunakar A; Saha A; Ray BK Diabetes Metab Syndr; 2021; 15(5):102267. PubMed ID: 34509790 [TBL] [Abstract][Full Text] [Related]
11. COVID-19-associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis. Bhattacharyya A; Sarma P; Kaur H; Kumar S; Bhattacharyya J; Prajapat M; Prakash A; Sharma S; Reddy DH; Thota P; Bansal S; Gautam BS; Medhi B Indian J Pharmacol; 2021; 53(6):499-510. PubMed ID: 34975140 [TBL] [Abstract][Full Text] [Related]
12. Susceptibility of severe COVID-19 patients to rhino-orbital mucormycosis fungal infection in different clinical manifestations. Bayram N; Ozsaygılı C; Sav H; Tekin Y; Gundogan M; Pangal E; Cicek A; Özcan İ Jpn J Ophthalmol; 2021 Jul; 65(4):515-525. PubMed ID: 34057620 [TBL] [Abstract][Full Text] [Related]
13. Case series of central retinal artery occlusion in COVID-19-associated rhino-orbital-cerebral mucormycosis. Kamath GM; Jeganathan S; Salim S; Antony RM; Kamath AR; Hiran H Indian J Ophthalmol; 2023 Jul; 71(7):2904-2906. PubMed ID: 37417144 [TBL] [Abstract][Full Text] [Related]
14. Optic nerve thickening and infarction as the first evidence of orbital involvement with mucormycosis. Alsuhaibani AH; Al-Thubaiti G; Al Badr FB Middle East Afr J Ophthalmol; 2012; 19(3):340-2. PubMed ID: 22837632 [TBL] [Abstract][Full Text] [Related]
15. Unusual association of orbital tumour and rhino-orbital-cerebral mucormycosis. Verma R; Chakraborty R BMJ Case Rep; 2022 Aug; 15(8):. PubMed ID: 35999020 [TBL] [Abstract][Full Text] [Related]
16. Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients. Nair AG; Adulkar NG; D'Cunha L; Rao PR; Bradoo RA; Bapaye MM; Kothari A; Dave TV; Shinde CA Orbit; 2021 Dec; 40(6):499-504. PubMed ID: 34338124 [TBL] [Abstract][Full Text] [Related]
17. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1. Sen M; Honavar SG; Bansal R; Sengupta S; Rao R; Kim U; Sharma M; Sachdev M; Grover AK; Surve A; Budharapu A; Ramadhin AK; Tripathi AK; Gupta A; Bhargava A; Sahu A; Khairnar A; Kochar A; Madhavani A; Shrivastava AK; Desai AK; Paul A; Ayyar A; Bhatnagar A; Singhal A; Nikose AS; Bhargava A; Tenagi AL; Kamble A; Nariani A; Patel B; Kashyap B; Dhawan B; Vohra B; Mandke C; Thrishulamurthy C; Sambare C; Sarkar D; Mankad DS; Maheshwari D; Lalwani D; Kanani D; Patel D; Manjandavida FP; Godhani F; Agarwal GA; Ravulaparthi G; Shilpa GV; Deshpande G; Thakkar H; Shah H; Ojha HR; Jani H; Gontia J; Mishrikotkar JP; Likhari K; Prajapati K; Porwal K; Koka K; Dharawat KS; Ramamurthy LB; Bhattacharyya M; Saini M; Christy MC; Das M; Hada M; Panchal M; Pandharpurkar M; Ali MO; Porwal M; Gangashetappa N; Mehrotra N; Bijlani N; Gajendragadkar N; Nagarkar NM; Modi P; Rewri P; Sao P; Patil PS; Giri P; Kapadia P; Yadav P; Bhagat P; Parekh R; Dyaberi R; Chauhan RS; Kaur R; Duvesh RK; Murthy R; Dandu RV; Kathiara R; Beri R; Pandit R; Rani RH; Gupta R; Pherwani R; Sapkal R; Mehta R; Tadepalli S; Fatima S; Karmarkar S; Patil SS; Shah S; Shah S; Shah S; Dubey S; Gandhi S; Kanakpur S; Mohan S; Bhomaj S; Kerkar S; Jariwala S; Sahu S; Tara S; Maru SK; Jhavar S; Sharma S; Gupta S; Kumari S; Das S; Menon S; Burkule S; Nisar SP; Kaliaperumal S; Rao S; Pakrasi S; Rathod S; Biradar SG; Kumar S; Dutt S; Bansal S; Ravani SA; Lohiya S; Ali Rizvi SW; Gokhale T; Lahane TP; Vukkadala T; Grover T; Bhesaniya T; Chawla U; Singh U; Une VL; Nandedkar V; Subramaniam V; Eswaran V; Chaudhry VN; Rangarajan V; Dehane V; Sahasrabudhe VM; Sowjanya Y; Tupkary Y; Phadke Y; Indian J Ophthalmol; 2021 Jul; 69(7):1670-1692. PubMed ID: 34156034 [TBL] [Abstract][Full Text] [Related]
18. "MuCovid-21" study: Mucormycosis at an Indian tertiary care centre during the COVID-19 pandemic. Kumar S; Choudhary R; Pandey VP J R Coll Physicians Edinb; 2021 Dec; 51(4):352-358. PubMed ID: 34882132 [TBL] [Abstract][Full Text] [Related]
19. Survival after rhino-orbital-cerebral mucormycosis in an immunocompetent patient. Fairley C; Sullivan TJ; Bartley P; Allworth T; Lewandowski R Ophthalmology; 2000 Mar; 107(3):555-8. PubMed ID: 10711895 [TBL] [Abstract][Full Text] [Related]
20. A fungal epidemic amidst a viral pandemic: Risk factors for development of COVID-19 associated rhino-orbital-cerebral mucormycosis in India. Vasanthapuram VH; Gupta R; Adulkar N; Nair AG; Bradoo RA; Hegde R; Singh U; Tadepalli S; Mukherjee B; Kamal S; Alam MS; Rao R; Ananthakrishna S; Backiavathy V; Murthy AK; D'Cunha L; Dudeja G; Joji A; Kiran A; Koka K; Goswami Mukhopadhyay M; Nisar SP; Rao PR; Shinde CA Orbit; 2023 Feb; 42(1):30-41. PubMed ID: 35192435 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]